Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 69, Issue 1-6, 1999, Pages 463-471

  Kandouz, M ^a   Lombet, A ^b   Perrot, J Y ^c   Jacob, D ^d   Carvajal, S ^b   Kazem, A ^d   Rostene, W ^b   Therwath, A ^a   Gompel, A ^a,b,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c Lab d'Hématologie Biologique   (France)

^d HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

11 [4 [[5 [(4,4,5,5,5 PENTAFLUOROPENTYL)SULFONYL]PENTYL]OXY]PHENYL]ESTRADIOL; 16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE; 4 HYDROXYTAMOXIFEN; ANDROGEN; ANDROSTANOLONE; ANTIESTROGEN; FULVESTRANT; GESTAGEN; ORG OM 38; PREGNANE DERIVATIVE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; TIBOLONE; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL STRAIN MCF 7; CELL SURVIVAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG POTENCY; FEMALE; FLOW CYTOMETRY; HORMONE ACTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

APOPTOSIS; BREAST NEOPLASMS; DIHYDROTESTOSTERONE; ESTROGEN ANTAGONISTS; HUMANS; PROGESTINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0033011090     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00069-2     Document Type: Conference Paper

References (28)

1. Gompel A., Malet C., Spritzer P., Lalardrie J.P., Kuttenn F., Mauvais-Jarvis P. Progestin effect on proliferation and 17β-hydroxysteroid-dehydrogenase activity in normal breast cells in culture. J. Clin. Endocrinol. Metab. 63:1986;1174-1180.
2. Musgrove E.A., Lee C.S.L., Sutherland R.L. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of TGFα, EGF receptor, c-fos and c-myc genes. Mol. Cell. Biol. 11:1991;5032-5043.
3. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue-kinetics. Br. J. Cancer. 26:1972;239-257.
4. Ferguson D.J.P., Anderson T.J. Morphological evaluation of cell turnover in relation to the menstrual cycle in 'resting' human breast. Br. J. Cancer. 44:1981;177-181.
5. Kyprianou M., English H.F., Davidson N.E., Isaacs J.T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51:1991;162-166.
6. Perry P.R., Kang Y., Greaves B. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and independent human breast cells. Ann. Surg. Oncol. 2:1995;238-245.
7. Korsmeyer S.J. Bcl-2 an antidote to programmed cell death. Cancer Sur. 15:1992;105-118.
8. Vaux D.L., Cory S., Adams J.M. bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442.
9. Lu Q.L., Hanby A.M., Nasser Hajibagheri M.A., Gschmeissner S.E., Lu P.J., Taylor-Papadimitrou J., Krajewski S., Reed J.C., Wright N.A. Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J. Cell. Sci. 107:1994;363-371.
10. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homologue bax that accelerates programmed cell death. Cell. 74:1993;609-619.
11. L and bcl-2, displaces bax and promotes cell death. Cell. 80:1995;285-291.
12. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
13. Willing G., Lippman M.E., Gelman E.P. Effects of steroid hormones and peptide growth factors on proto-oncogene c-fos expression in human breast cancer cells. Cancer Res. 48:1988;802-805.
14. Klooesterboer H.J., Schoonen W.G.E.J., Deckers G.H., Klijn J.G.M. Effects of progestagens and OrgOD14 in in vitro and in vivo tumor models. J. Steroid Biochem. Mol. Biol. 49:1994;311-318.
15. Markiewicz L., Gurpide E. In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (OrgOD14) and its metabolites on human endometrium. J. Steroid Biochem. 35:1990;535-541.
16. Majno G., Joris I. Apoptosis, oncosis and necrosis. Am. J. Pathol. 146:1995;3-15.
17. Earnshaw W.C. Nuclear changes in apoptosis. Current Opinion Cell Biology. 7:1995;337-343.
18. Kandouz M., Siromachkova M., Jacob D., Marquet C., Therwath A., Gompel A. Int. J. Cancer. 68:1996;120-125.
19. Ellis P., Saccani-Jotti G., Clarke R., Johnston S.R.D., Anderson E., Howell A., A'Hern R., Salter J., Detre S., Nicholson R., Robertson J., Smith I.E., Dowsett M. Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. Int. J. Cancer. 72:1997;608-613.
20. Howell A., DeFriend D.J., Robertson J.F.R., Blamey R.W., Anderson L., Anderson E., Sutcliffe F.A., Walton P. Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer. Br. J. Cancer. 74:1996;300-308.
21. Paech K., Webb P., Kuiper G.G.J.M., Nilsson S., Gustafsson J.A., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites. Science. 277:1997;1508-1510.
22. Herrmann J.L., Bruckheimer E., McDonnell T.J. Cell death signal transduction and bcl-2 function. Bioch. Soc. Transactions. 24:1996;1059-1065.
23. Sabourin J.C., Martin A., Baruch J., Truc J.B., Gompel A., Poitout Ph. Bcl-2 expression in normal breast tissue during the menstrual cycle. Int. J. Cancer. 59:1994;1-6.
24. Gompel A., Sabourin J.C., Martin A., Audoin J., Yaneva H., Decroix Y., Poitout Ph. Bcl-2 expression in normal endometrium during the menstrual cycle. Amer. J. Pathol. 144:1994;1195-1202.
25. Teixeira C., Reed J.C., Pratt M.A.C. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55:1995;3902-3907.
26. Leung L.K., Do L., Wang T.T.Y. Regulation of death promoter Bak expression by cell density and 17β estradiol in MCF-7 cells. Cancer Letters. 124:1998;47-52.
27. Hurd C., Khattree N., Alban P., Nag K., Jhanwar S.C., Dinda S., Moudgil V.K. Hormonal regulation of the p53 tumor suppressor protein in T47-D cancer cells. J. Biol. Chem. 270:1995;28507-28510.
28. Hurd C., Khattree N., Dinda S., Alban P., Moudgil V.K. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells. Oncogene. 15:1997;991-995.